Trial Information
Predictive Factors for Major Bleeding Risk in Patients Admitted in a Palliativecare Unit - Etude RHESO - Etude Monocentrique
Inclusion Criteria:
- 18 years
- admitted in a palliative care unit for a cancer, a pulmonary, a cardiac or a
neurologic advanced disease
Exclusion Criteria:
- life prognosis less than 48 hours
- patients treated with curative doses of antithrombotic therapy
- patients with follow up of 3 months is not possible
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
The primary outcome is the symptomatic occurrence of major and clinical relevant bleeding during the three months study period.
Outcome Time Frame:
3 month
Safety Issue:
No
Principal Investigator
Bernard TARDY, PHD
Investigator Role:
Study Director
Investigator Affiliation:
CIC-EC (CIE3)
Authority:
France: French Data Protection Authority
Study ID:
0908039
NCT ID:
NCT01056978
Start Date:
April 2010
Completion Date:
October 2012
Related Keywords:
- Hemorrhage
- palliative care unit
- bleeding
- thromboembolic
- hemorrhagic risk
- antithrombotic prophylaxis
- Hemorrhage